Cartiva is a synthetic cartilage implant that is used to treat great toe arthritis, also known as hallux limitus and hallux rigidus, one of the most common conditions we treat at UFAI.
The FDA has recently approved Cartiva, a gel-like implant designed to act as a replacement for arthritic joint tissue.
The gel material mimics the quality and density of bone, eliminating the problematic side effects of metal implants, which can damage or become absorbed by the bone over time.
Dr. Bob Baravaria DPM, FACFAS is a Board-Certified Podiatric Foot and Ankle Specialist. He is an assistant clinical professor at the UCLA School of Medicine and serves as Director of University Foot and Ankle Institute.
Dr. Baravarian has been involved in athletics his entire life and played competitive tennis in high school and college. He has an interest in sports medicine, arthritis therapy, and trauma/reconstructive surgery of the foot and ankle. He is also fluent in five languages (English, French, Spanish, Farsi, and Hebrew),